Peter the Bridge, Saint Petersburg, Russia

News from NEOMED

CDRD and NEOMED Institute Join Forces to Create a New Pan-Canadian Enterprise adMare BioInnovations

May 30th, 2019 |Announcement| No Comments
Vancouver, BC and Montreal, QC – May 30, 2019: Two successful Canadian innovation organizations, CDRD, Canada’s national life sciences venture, and NEOMED Institute, a leading not-for-profit R&D organization building an innovation ecosystem in Montréal, are pleased to announce that effective today, they are bringing their

Read complete news

Hope on the horizon for hard-to-treat breast cancers

May 14th, 2019 |Announcement| No Comments
Montreal, Canada, May 14, 2019 - The NEOMED Institute (NEOMED), CQDM, the Canadian Cancer Society (CCS), the Goodman Cancer Research Centre (GCRC) and the Lady Davis Institute (LDI) announced today a unique multi-party collaboration to develop new anti-cancer therapies. This collaboration is intended to more rapidly advance two

Read complete news

EFFERVESCENCE 2019: NEOMED Institute will co-host a conference on SMEs financing

April 8th, 2019 |Announcement| No Comments
Montreal, Quebec, Canada, April 8th 2019– As part of this unique event, developed by a collective of 14 lead organizations in the LSHT (Life Sciences and Health Technologies) sector in Quebec, the NEOMED Institute will present the theme "Public-Private Collaborations: leverage for financing?" with the participation of the AmorC

Read complete news

The NEOMED Institute is pleased to be one of the 14 organizing partners of the EFFERVESCENCE event The future of life sciences

March 1st, 2019 |General| No Comments
Montreal, Quebec, Canada, March 1st 2019 – Developed by a collective of 14 lead organizations in the LSHT (Life Sciences and Health Technologies) sector in Quebec, including the NEOMED Institute, EFFERVESCENCE is the new key business event for all major players in the future of life sciences. A true scientific and business h

Read complete news

© 2019 NEOMED Institute. All Rights Reserved. // Solutions Web Globalia